PRKD1 and breast cancer: It is thus tempting to speculate that PKD/PKCμ contributes, together down-regulation of GSK3β and up-regulation of p42/p44-MAPK to the MDR-phenotype in breast cancer, concomitantly driving MMP-9 overexpression and thus metastasis.